UNI-ASIA Logo WATA Logo
news img
Professor Liao Zhengyin, Distinguished Expert of Chengdu Huanya Hospital, Delivered a Featured Presentation at APSCVIR 2026
2026-06-19
From June 11 to 14, 2026, the 20th Asia-Pacific Society of Cardiovascular and Interventional Radiology Congress (APSCVIR 2026) was held at the Suzhou International Expo Center. As one of the most influential academic conferences in the Asia-Pacific region for interventional radiology and minimally invasive therapy, this year's congress brought together interventional specialists, clinical researchers, and young scholars from numerous countries and regions worldwide to exchange the latest advances in tumor intervention, vascular interventional therapy, translational applications of new technologies, and other cutting-edge topics.
news img
International Cancer Survivors Month
2026-06-07
National Cancer Survivors Day usually refers to the event held on the first Sunday of June each year. It is dedicated to celebrating the lives, hope, and resilience of cancer survivors, while raising public awareness of the long-term needs of cancer survivors.
news img
Honoring Teachers, Carrying Forward the Medical Legacy | A Heartwarming Visit of Interventional Radiology Pioneer Professor Zhang Jinshan to Chengdu Uni-Asia Cancer Hospital
2026-06-03
On May 31, 2026, Chengdu Huanya Hospital welcomed a distinguished guest—Professor Zhang Jinshan, one of the pioneers of interventional radiology in China and former professor at the PLA General Hospital (301 Hospital). Accompanied by his wife, Professor Zhang visited our hospital for academic guidance and meaningful exchanges.
news img
Professor Liao Zhengyin, Specially Appointed Expert of Our Hospital, Invited to Deliver a Special Lecture at the 17th Western China Interventional Radiology Academic Conference
2026-06-03
From May 28 to 31, 2026, the 17th Western China Interventional Radiology Academic Conference and the 2026 Yunnan Medical Association Academic Conference on Interventional Medicine were successfully held in Kunming, Yunnan Province. Professor Liao Zhengyin, a specially appointed expert of our hospital and a renowned interventional radiology specialist in China, was invited to attend the conference and deliver a special academic lecture.
news img
Professor Liao Zhengyin has been elected as the vice president of the Interventional Medicine Branch within the Sichuan International Medical Exchange & Promotion Association
2026-05-29
On May 23, 2026, the re-election meeting of the Interventional Medicine Branch of the Sichuan Association for the Promotion of International Medical Exchange (referred to as the “Sichuan Medical Promotion Association”) was successfully concluded in Chengdu. Interventional medicine experts from major hospitals across the province gathered to witness the establishment of the new branch leadership.
news img
Global Launch of “World Ablation Day”! UNI-ASIA Cancer Hospital Becomes One of the First Medical Institutions Worldwide to Receive This International Certification
2026-05-19
Under the global spotlight of the field of oncology treatment, the inaugural academic conference of the World Ablation Therapy Association officially opened. The conference was not only a concentrated showcase of cutting-edge achievements in ablation technology, but also witnessed a historic moment: the global launch of “World Ablation Day,” announcing that minimally invasive cancer treatment has officially entered a new era.
news img
Strengthening the Foundation Through Training, Preparing for Action Through Drills — Our Hospital Conducts April “Three Basics” Training and Emergency Drill to Reinforce the Medical Safety Line
2026-04-18
To further consolidate the professional foundation of our medical staff and enhance our hospital's emergency response and multidisciplinary collaborative treatment capabilities for critically ill patients, the Medical Affairs Department carefully organized the April 2026 “Three Basics” training and clinical emergency drill on the afternoon of April 15.
news img
Spring Sets the Year in Motion, Action Comes First | Our Hospital Holds the 2026 New-Year Work Mobilization Meeting
2026-02-28
Spring sets the year in motion, and action comes first. On February 24, the first working day after the Spring Festival holiday, our hospital held the 2026 new-year work mobilization meeting.
news img
Pragmatic Innovation · Steady Progress for Long-Term Success — Zigong High-Tech Cancer Hospital × Chengdu Uni-Asia Cancer Hospital 2026 New Year Summary and Commendation Conference Successfully Held
2026-02-14
On February 10, 2026, the New Year Summary and Commendation Conference of Zigong High-Tech Cancer Hospital and Chengdu Uni-Asia Cancer Hospital concluded successfully. Colleagues from both hospitals gathered together, igniting passion through competition, paying tribute to dedication through honors, and opening a new journey through song.
news img
Warm Laba Porridge, Warm Hearts — Sending Festival Blessings to Inpatients
2026-01-31
“Children, children, don't be greedy; after Laba comes the New Year.” The Laba Festival marks the prelude to the New Year and carries wishes for reunion and well-being. Early on January 26, bowls of carefully prepared, steaming Laba porridge were delivered by medical staff to the wards.
news img
Strengthening the Safety Line | Our Hospital Conducts a Pre-Spring Festival Fire Emergency Drill
2026-01-09
As the Spring Festival approached, in order to comprehensively improve the hospital's fire safety management, strengthen all staff's fire safety awareness and emergency response capabilities, and build a strong safety line during the holiday period, our hospital organized a pre-Spring Festival fire safety learning and drill activity on the afternoon of January 8.
news img
Our Laboratory Director Liao Yang Returns with Honors After Competing as a Member of the Provincial Health Commission Team!
2025-11-29
Recently, the 2025 “Haorentang Cup” Table Tennis Competition, themed “Pingbo Health, Renxing Tongxin,” concluded successfully. In this fierce contest that brought together top players from across the province, our Laboratory Director Liao Yang competed as a member of the Provincial Health Commission team.
news img
Fulfilling the Dual Mission of Technological Leadership and Medical Humanism — Chengdu Uni-Asia Cancer Hospital Co-Hosts the 2025 Palliative Care Professional Committee Conference
2025-11-22
From November 21 to 22, 2025, the “2025 Palliative Care Professional Committee Conference and NanoKnife Ablation Clinical Application Symposium,” hosted by the Sichuan Medical Doctor Association and organized by its Palliative Care Professional Committee, will be held grandly at Chengdu Longemont Hotel. As one of the important co-organizers, Chengdu Uni-Asia Cancer Hospital is deeply involved in this academic event.
news img
Thirty-Six Years of West China Dedication, A New Journey Begins Today! Head Nurse Chen Huirong Officially Joins Our Hospital
2025-11-15
Recently, our hospital welcomed the new leader of the Nursing Department — Head Nurse Chen Huirong, who came from West China Hospital to our hospital. This nursing career spanning thirty-six years now writes a new chapter.
news img
Health Care Enters the Nursing Home: Director Wu Chaobo Brings a Heartwarming Lecture on Tumor Prevention and Treatment
2025-11-15
Winter warmth, health companionship. To further improve health awareness among elderly friends, on the morning of November 13, Dr. Wu Chaobo, Director of Ward II of our hospital, visited a nursing home and gave a thoughtful public welfare lecture on tumor prevention and treatment, transforming professional health knowledge into warm daily protection.
news img
Sichuan General Chamber of Commerce Youth Committee Youth Service Day, Session 5 — A Record of the Visit to Uni-Asia Cancer Hospital
2025-10-16
On October 16, 2025, the Youth Service Day event themed “Walking Together for Health, Building the Future Together,” organized by the Youth Committee of the Sichuan General Chamber of Commerce, was successfully held at Chengdu Uni-Asia Cancer Hospital.
MDT Team
Bringing together senior experts in China's precision minimally invasive cancer treatment field to provide you with world-leading minimally invasive cancer treatment services.
More Doctors
Liao Zhengyin
Liao Zhengyin
Professor, M.D., Chief Physician, Grade 1 Expert⁽¹⁾ in the Oncology Center at West China Hospital, Sichuan University⁽²⁾ , Postdoctoral Fellow, Chinese PLA General Hospitals in Beijing, China⁽³⁾, Senior Visiting Scholar at Johns Hopkins Hospital, USA
Extremely adept at minimally invasive interventional therapies for tumors and treatment of cancer pain, proficient in radioactive seed implantation, ablation, and vascular intervention, with a focus on liver cancer, lung cancer, pancreatic cancer, and bone metastases, and particularly skilled in radioactive seed implantation for refractory cancer pain.
Details
Zhang Jinshan
Zhang Jinshan
Professor, M.D., Doctoral Supervisor, Chief Physician, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital⁽¹⁾, Ph.D. of Medicine, Nagasaki University, Japan
He is very involved in treating tumors and blood vessel diseases, focusing on less invasive procedures for issues like liver cancer, cirrhotic portal hypertension, Budd–Chiari syndrome, narrowing and blockage of peripheral blood vessels, both benign and malignant tumors, and benign prostatic hyperplasia. He was among the first in China to perform advanced techniques such as TIPSS and B-ORTO, filling multiple domestic gaps in the field. He also pioneered temporary hepatic vein occlusion combined with hepatic arterial embolization for the treatment of liver cancer, led the development of standardized treatment protocols for liver cancer, and has made significant contributions to the advancement of interventional medicine in China.
Details
Xiao Yueyong
Xiao Yueyong
Professor, M.D., Chief Physician, Doctoral Supervisor, Chief Physician at Department of Radiological Diagnosis of Chinese PLA General Hospital⁽¹⁾
Doctor Xiao has an expertise in the individualised minimally-invasive ablation of solid tumours including liver cancer, lung cancer, and pancreatic cancer under the guidance of CT/MRI. Doctor Xiao is proficient in radiofrequency, microwave, cryoablation, and nanoknife ablation technologies, and operates more than thousands of operations annually. Especially, Dr. Xiao has abundant experiences in the precise treatment of the tumours in special anatomical sites such as hepatic hilar region, retroperitoneum, and mediastinal lymph nodes. Further, Dr. Xiao is rather good at combining chemical ablation and seed implantation therapies.
Details
Hu Xiaokun
Hu Xiaokun
Professor, M.D., Chief Physician, Doctoral Supervisor, Postdoctoral mentor, Deputy Director of the Interventional Medicine Center of The Affiliated Hospital of Qingdao University, Director of the Qingdao Tumor Interventional Minimally Invasive Technology Innovation Center., Visiting Scholar at Harvard Medical School, USA
Specializes in the treatment of solid tumors, including lung cancer, liver cancer, glioma, and pancreatic cancer, with a particular focus on radioactive iodine-125 seed implantation combined with multimodal ablation techniques such as microwave ablation, radiofrequency ablation, cryoablation, and irreversible electroporation (NanoKnife). Also possesses extensive experience in the management of non-neoplastic diseases, particularly vertebroplasty and minimally invasive treatments for intervertebral disc disorders.
Details
Treatment Technologies
Providing targeted, world-class precision treatment solutions for patients worldwide.
More Treatments
Transarterial Chemoembolization (TACE)
It is primarily used for the palliative treatment of intermediate to advanced-stage primary liver cancer, liver metastases, and hypervascular tumors in areas such as the head, neck, and lungs. It can also be used as postoperative adjuvant chemotherapy to help reduce the risk of local recurrence.
NanoKnife Ablation Technology
It is primarily indicated for solid tumors located in anatomically complex regions adjacent to major blood vessels, bile ducts, pancreatic ducts, the intestines, or nerves—such as locally advanced pancreatic cancer, hilar hepatic tumors, renal hilar tumors, and prostate cancer. This technique offers a safe and effective option for curative or cytoreductive treatment in patients with unresectable lesions or tumors unsuitable for conventional thermal ablation.
Iodine-125 Seed Implantation Technology
It is primarily indicated for solid tumors that are unresectable, recurrent, or metastatic after radiotherapy and chemotherapy, including primary liver cancer, non-small cell lung cancer, prostate cancer, and pancreatic cancer, as well as recurrent or metastatic tumors of the head and neck and pelvic regions.
Argon-Helium Knife Ablation Therapy
It is widely used in the treatment of liver cancer, lung cancer, renal cancer, as well as bone and soft tissue tumors. The technique is particularly suitable for lesions adjacent to the thoracic or abdominal wall, adrenal glands, and multiple metastatic tumors, making it an important component of the minimally invasive ablation system for solid tumors.
Patient stories
At UNI-ASIA Cancer Hospital, every journey in search of care is marked by courage and hope, and every story bears witness to doctors and patients working together to overcome disease.
More Cases
Mr.Wang
Liver Cancer
Mr.Wang
China
A 71-year-old Chinese patient was diagnosed with liver cancer. Because the tumor was adjacent to major blood vessels and the patient was elderly and physically weak, he visited multiple hospitals over three years and was repeatedly told that surgery was not possible and that he could not tolerate chemotherapy. No effective treatment options remained. After being referred to Uni-Asia Cancer Hospital, he underwent three sessions of transarterial chemoembolization (TACE). He recovered smoothly after the procedures, and follow-up examinations showed that the tumor had almost disappeared, achieving clinical cure. He has now returned to his orchard and resumed normal life.
Wang Xiaocai
Lung Cancer
Wang Xiaocai
China
Chinese patient, diagnosed with stage IIIb lung adenocarcinoma with hilar, mediastinal, and cervical lymph node metastasis. Due to the deep and multiple locations of the tumors, and because the patient experienced no subjective symptoms, he feared open surgery and the side effects of chemotherapy and refused conventional treatment. After referral to Uni-Asia Cancer Hospital, he underwent transarterial chemoembolization (TACE) of the tumor-feeding arteries. He was able to get out of bed the day after the procedure, recovered well, has since returned to normal life, and is awaiting subsequent cycles of treatment.
Liu Heyi
Liver Cancer
Liu Heyi
China
A Chinese patient was diagnosed with liver cancer accompanied by severe bile duct obstruction, severe systemic jaundice, and a weight loss of nearly 15 kg within one month. His bilirubin level was as high as 257.50 umol/L. Because the tumor was adjacent to major blood vessels, several hospitals assessed that surgical resection would carry an excessively high risk. After being referred to UNI-ASIA Cancer Hospital, he underwent two interventional treatments. He recovered quickly after the procedures, was able to get out of bed the next day, his jaundice subsided, his weight stabilized, and he has now returned to normal life.
Chen De
Bladder Cancer
Chen De
China
A Chinese patient presented with recurrent bladder cancer six years after initial surgery, accompanied by liver metastasis and abdominal aortic thrombosis. The MDT at West China Hospital recommended radical cystectomy, but the patient declined due to concerns about his physical condition. After undergoing interventional therapy at our hospital, his demeanor shifted markedly — from withdrawn and largely silent before treatment to actively engaging in conversation with his family afterward. His pain has lessened, and he now awaits the next cycle of treatment with renewed confidence.

Consultation

Consultation Type
Name
Gender
Date of Birth
Nationality
Country of Residence
Phone Number
Email
Your Question
Privacy Policy and Statement

Submitted Successfully

We have received your consultation. Thank you for your trust. A specialist will contact you within 72 hours, so please keep an eye on your phone calls and email.
Book Appt. WhatsApp
Call Us